window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 13, 2026

  • News
  • About Us
Contact Us

autoimmune disease

  • Biotech,Drug Development,Immunology,Research & Development

    Nucleome Therapeutics nominates first preclinical development candidate for inflammatory diseases

    Nucleome Therapeutics has nominated its first preclinical development candidate, marking [...]

    January 8, 2026
  • Artificial Intelligence,Biotech,Chronic diseases,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development,Single Cell analysis,Technology and platforms

    Immunai signs $85 million AstraZeneca deal to advance inflammatory bowel disease target

    Immunai has signed an agreement worth up to $85 million [...]

    October 16, 2025
  • European biotech,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development

    Enhanced Genomics extends Series A to $19m to advance autoimmune therapeutics pipeline

    Enhanced Genomics has secured an additional funding round, bringing its [...]

    September 22, 2025
  • Clinical Trials,Pharmaceuticals and therapeutics,Regulatory Affairs

    J&J halts Imaavy rheumatoid arthritis trial after no added benefit

    Johnson & Johnson has dropped plans to develop its recently [...]

    September 14, 2025
  • Biologics & Biosimilars,Clinical Development,Drug Development,Rare Diseases,Regulatory Affairs

    FDA grants fast track to Nektar’s rezpegaldesleukin for severe alopecia areata

    Nektar Therapeutics has received FDA Fast Track designation for its [...]

    July 29, 2025
  • Cell & Gene Therapy,Clinical Development,Clinical Trials,Oncology

    Novotech report explores how in-vivo CAR-T could transform cell therapy access and costs

    A new whitepaper from Novotech has outlined how in-vivo CAR-T [...]

    July 18, 2025
  • Biologics & Biosimilars,Precision medicine

    Enhanced Genomics appoints biotech veteran Dietrich Stephan as chair to drive next-gen target discovery

    Enhanced Genomics has appointed leading biotechnology entrepreneur Dietrich Stephan as [...]

    June 12, 2025
  • Cell & Gene Therapy,Drug Development,Technology and platforms

    Commit Biologics launches Scientific Advisory Board to accelerate BiCE platform development

    Commit Biologics has announced the formation of a Scientific Advisory [...]

    June 9, 2025
  • Clinical Trials,Drug Development,Patient Centricity,Regulatory Affairs

    NICE backs mirikizumab for treatment-resistant Crohn’s disease

    The National Institute for Health and Care Excellence (NICE) has [...]

    May 30, 2025
  • Cell & Gene Therapy

    GeneFab and RegCell partner to advance autoimmune Treg therapy toward US trials

    May 7, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Trenchant BioSystems confirms AutoCell platform can cut CGT manufacturing to 2.5 days
    Categories: Biomanufacturing, Cell & Gene Therapy, Clinical Development, Drug Development, Technology and platforms
  • Neuraxpharm expands ADHD treatment options in Europe with Tuzulby and Paxneury launches
    Categories: Central Nervous System, Child & Adolescnt Health, Drug Development, Pharmaceuticals and therapeutics
  • FluoSphera raises €1.23 million to scale human-based preclinical testing platform
    Categories: Artificial Intelligence, Drug Development, European biotech, Partnerships & Funding, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top